Aveni Foundation Logo

MIP Score

53

Med Research
Cancer Research

Aveni Foundation

Mission

The Aveni Foundation supports the timely development of innovative targeted therapies for cancer and other diseases, thereby addressing a significant global health concern as cancer is a leading cause of death worldwide. The foundation is named in honor of Fr. Joseph Aveni, a priest who benefitted from a gene-targeted therapy.

Basic Information

Tax-Exempt

Address

2700 Neilson Way, Apt 1227, Santa Monica, California, 90405

View all Santa Monica charities

Founded in

2018

EIN

83-0731767

Total Assets

$381.9 thousand

UN Sustainable Development Goals Supported

This organization contributes to the following United Nations Sustainable Development Goals. See the SDG page for more information.

Showing 1 of 1 goals

At a Glance

Impact of DeltaRex-G

Impact of DeltaRex-G

Ruth Oliver, fifteen year pancreatic cancer survivor with DeltaRex-G.

Advancing Gene Therapy

Advancing Gene Therapy

Kendra Krause, fifteen year sarcoma 'NERD' (No Evidence of Recurring Disease) with DeltaRex-G.

Aveni Foundation Events

Aveni Foundation Events

An inspired performance by Gustavo Santaolalla in support of Aveni Foundation.

MIP Score (Beta)

The MIP Score is in beta! We'd love any feedback you may have.

The MIP Score and it's methodology is purely used as a way to visualize how a nonprofits public financial data compares against others. It doesn't reflect the unique circumstances and impact that a nonprofit has.The MIP Score should never be used to say one charity is better than another.

Overall Score

53

52

/100

Program Expense Ratio

87.10%

18

/20

Program Revenue Growth

0.00%

2

/20

Leverage Ratio

0.0007175

20

/20

Working Capital Ratio

0.8091

10

/20

Fundraising Efficiency

0

2

/20

Latest Filing Data: Form 990

Fiscal Year:2023

Source:Source: Self-reported by organization

Financial Details

Revenue

CategoryAmountPercentage
Contributions, Gifts, and Grants708.7K100.00%
Program Services00.00%
Investment Income40.00%
Sales of Non-Inventory Assets00.00%
Other Notable Sources00.00%
Total Revenue708.7K100.00%